158 related articles for article (PubMed ID: 6819493)
1. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
Yarbrough GG; Faison EP; Antolik EK
Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
Gattaz WF; Emrich A; Behrens S
J Neural Transm Gen Sect; 1993; 92(2-3):197-201. PubMed ID: 8369109
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
4. Choline chloride in animal models of tardive dyskinesia.
Davis KL; Hollister LE; Vento AL; Simonton S
Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830
[No Abstract] [Full Text] [Related]
5. Estrogen in experimental tardive dyskinesia.
Gordon JH; Borison RL; Diamond BI
Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
[TBL] [Abstract][Full Text] [Related]
6. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
Koller W; Curtin J; Fields J
Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
[TBL] [Abstract][Full Text] [Related]
7. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
8. The effect of lithium on an animal model of tardive dyskinesia.
Klawans HL; Weiner WJ; Nausieda PA
Prog Neuropsychopharmacol; 1977; 1(1-2):53-60. PubMed ID: 569341
[No Abstract] [Full Text] [Related]
9. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
[TBL] [Abstract][Full Text] [Related]
11. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
12. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
Fuchs V; Coper H; Strauss S; Rommelspacher H
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
[TBL] [Abstract][Full Text] [Related]
13. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.
Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF
Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231
[TBL] [Abstract][Full Text] [Related]
14. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
Kinon BJ; Merson D; Kane JM
Psychopharmacology (Berl); 1984; 84(3):347-51. PubMed ID: 6440181
[TBL] [Abstract][Full Text] [Related]
15. Estradiol, TRH and striatal dopaminergic mechanisms.
Bédard PJ; Malouin F; Dipaolo T; Labrie F
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):555-61. PubMed ID: 6819600
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dopamine receptor sensitivity by estrogen.
Gordon JH; Borison RL; Diamond BI
Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
[TBL] [Abstract][Full Text] [Related]
17. Oral tardive dyskinesia in the rat.
Sundén-Kuronen B; Pohto P; Alanen E
Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673
[TBL] [Abstract][Full Text] [Related]
18. Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats.
Verimer T; Arnerić SP; Long JP; Walsh BJ; Abou Zeit-Har MS
Psychopharmacology (Berl); 1981; 75(3):273-6. PubMed ID: 6275446
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
Porreca F; Cowan A; Tallarida RJ
Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
[No Abstract] [Full Text] [Related]
20. Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.
Ushijima I; Yamada K; Noda Y; Furukawa T
Psychopharmacology (Berl); 1982; 76(1):1-4. PubMed ID: 6281836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
